logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MICROPORT NEURO (02172) spent approximately HKD 1.9513 million to repurchase 250,000 shares on September 19th.

date
20:35 19/09/2024
avatar
GMT Eight
Minimally Invasive Neurosciences (02172) announced on September 19, 2024, to repurchase approximately 1.9513 million Hong Kong dollars...
MICROPORT NEURO (02172) has announced on September 19, 2024, that they will repurchase 250,000 shares at a cost of approximately 1.9513 million Hong Kong dollars. The repurchase price per share is between 7.77 and 7.86 Hong Kong dollars.
Related Articles
HK Stock
AIM VACCINE (06660): Iterative process efficiently completes phase III clinical on-site work for human diploid rabies vaccine.
HK Stock
Pharmaron Beijing (03759) plans to offer a discount of approximately 8.50% for a total of 58.44 million shares, raising a net amount of approximately 1.319 billion Hong Kong dollars.
New Stock News | Yino Pharma submits application to Hong Kong Stock Exchange
AIM VACCINE (06660): Iterative process efficiently completes phase III clinical on-site work for human diploid rabies vaccine.
HK Stock
Pharmaron Beijing (03759) plans to offer a discount of approximately 8.50% for a total of 58.44 million shares, raising a net amount of approximately 1.319 billion Hong Kong dollars.
HK Stock
New Stock News | Yino Pharma submits application to Hong Kong Stock Exchange
RECOMMEND
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
icon
14/01/2026
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
icon
14/01/2026
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
icon
14/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.